AstraZeneca is committing tens of billions of dollars to expand its production and research facilities in the United States, aiming to strengthen supply chain resilience and reduce reliance on foreign suppliers. This strategic move follows a recent significant data breach claimed by the hacker group LAPSUS$, raising concerns about the security of sensitive internal information. As the company navigates these challenges, its oncology sales remain strong, particularly with Imfinzi's recent EU approvals, positioning AstraZeneca for potential growth despite current pressures.
“Bugün de 1 AZN ≈ 26,04-26,05 TL seviyesinde seyrediyor (Wise, Xe verileri).”
“Şu an 1 AZN ≈ 26.05 TL. TL'nin enflasyon ve değer kaybıyla Manat TL karşısında güçleniyor, 1 yılda %17+ yükseldi. Kısa vadede 27 TL'yi görebilir ama tahmin değil, piyasa dalgalı.”
“China's Commerce Minister Wang Wentao met today with PhRMA CEO Stephen Ubl and execs from Novartis, AstraZeneca, Roche, Boehringer Ingelheim, and Organon. They discussed the business environment for foreign pharma firms in China. Wang highlighted the 15th Five-Year Plan naming biopharma a key industry, plus plans for stronger IP protection and policy transparency to draw more investment—part of broader efforts to reverse declining FDI with tax breaks and incentives.”
“The notorious hacking collective LAPSUS$ has resurfaced, allegedly claiming responsibility for a significant data breach involving the multinational pharmaceutical and biotechnology company AstraZeneca.”
“Pharmaceutical giants like Johnson & Johnson, AstraZeneca, and Eli Lilly are committing tens of billions of dollars to expand production and research facilities in the United States. Those investments strengthen domestic supply chains for critical medicines and treatments.”
“Producing more pharmaceuticals at home reduces dependence on foreign suppliers for essential health products. For American patients and healthcare providers, that shift means greater reliability and national resilience.”
“Hacker Group LAPSUS$ Claims Alleged AstraZeneca Data Breach”
“Key companies & profits: - AstraZeneca: ~$6B sales; minimal profit (no-profit pledge).”
“Pharmaceutical giants like Johnson & Johnson, AstraZeneca, and Eli Lilly are committing tens of billions of dollars to expand production and research facilities in the United States. Those investments strengthen domestic supply chains for critical medicines and treatments.”
“Yes, the 2024 GVDN study (published in Vaccine journal) analyzed 99 million people across 8 countries and found statistically significant increases in rare conditions: myocarditis/pericarditis after mRNA vaccines (Pfizer/Moderna), and Guillain-Barré syndrome/cerebral venous thrombosis after AstraZeneca.”
“Bu 6 şirket onkolojiye hakim ve imparatorluklarını tehdit eden her şeyi bastırıyor.”
“🔴 AstraZeneca piratée (code source, cloud AWS/Azure, clés privées) : des données sensibles revendiquées par le groupe LAPSUS$ Le groupe de hackers LAPSUS$ revendique le piratage du géant pharmaceutique AstraZeneca et affirme détenir plusieurs gigaoctets de données sensibles.”